TITLE

Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda

AUTHOR(S)
Kipp, Walter; Konde-Lule, Joseph; Rubaale, Tom; Okech-Ojony, Joa; Alibhai, Arif; Saunders, Duncan L.
PUB. DATE
January 2011
SOURCE
BMC International Health & Human Rights;2011 Supplement 2, Vol. 11 Issue Suppl 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Improved availability of antiretroviral therapy in sub-Saharan Africa is intended to benefit all eligible HIV-infected patients; however in reality antiretroviral services are mainly offered in urban hospitals. Poor rural patients have difficulty accessing the drugs, making the provision of antiretroviral therapy inequitable. Initial tests of community-based treatment programs in Uganda suggest that home-based treatment of HIV/AIDS may equal hospital-based treatment; however the literature reveals limited experiences with such programs. The research: This intervention study aimed to; 1) assess the effectiveness of a rural community-based ART program in a subcounty (Rwimi) of Uganda; and 2) compare treatment outcomes and mortality in a rural community-based antiretroviral therapy program with a well-established hospital-based program. Ethics approvals were obtained in Canada and Uganda. Results and outcomes: Successful treatment outcomes after two years in both the community and hospital cohorts were high. All-cause mortality was similar in both cohorts. However, community-based patients were more likely to achieve viral suppression and had good adherence to treatment. The community-based program was slightly more cost-effective. Per capita costs in both settings were unsustainable, representing more than Uganda's Primary Health Care Services current expenditures per person per year for all health services. The unpaid community volunteers showed high participation and low attrition rates for the two years that this program was evaluated. Challenges and successes: Key successes of this study include the demonstration that antiretroviral therapy can be provided in a rural setting, the creation of a research infrastructure and culture within Kabarole's health system, and the establishment of a research collaboration capable of enriching the global health graduate program at the University of Alberta. Challenging questions about the long-term feasibility and sustainability of a community-based ARV program in Uganda still remain. The partnership: This project is a continuation of previous successful collaborations between the School of Public Health of Makerere University, the School of Public Health of University of Alberta, the Kabarole District Administration and the Kabarole Research and Resource Center.
ACCESSION #
67741436

 

Related Articles

  • Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese HIV/AIDS Patients: Multicentric Observation Cohort. Taisheng Li; Yi Dai; Jiqiu Kuang; Jingmei Jiang; Yang Han; Zhifeng Qiu; Jing Xie; Lingyan Zuo; Yanling Li // PLoS Clinical Trials;Dec2008, Vol. 5 Issue 12, Special section p1 

    Background: The purpose of this study was to evaluate the efficacy and safety of three nevirapine-based antiretroviral treatments for adult antiretroviral-naïve Chinese patients with HIV-1 infection. Methodology: This was a prospective, multicenter study. 198 antiretroviral-naiuml;ve HIV-1...

  • Results of a Community-Based Antiretroviral Treatment Program for HIV-1 Infection in Western Uganda. Kipp, Walter; Konde-Lule, Joseph; Saunders, L. Duncan; Alibhai, Arif; Houston, Stan; Rubaale, Tom; Senthilselvan, Ambikaipakan; Okech-Ojony, Joa; Kiweewa, Francis // Current HIV Research;Mar2010, Vol. 8 Issue 2, p179 

    Objective: To compare the treatment outcomes and mortality in a rural community-based ART (CBART) program with a hospital-based ART program in the same district. Methods: The study design was a non-randomized cohort study consisting of 185 persons living with HIV (PLWHIV) in the CBART cohort and...

  • Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART. Worodria, William; Massinga-Loembe, Marguerite; Mayanja-Kizza, Harriet; Namaganda, Jane; Kambugu, Andrew; Manabe, Yukari C.; Kestens, Luc; Colebunders, Robert // Clinical & Developmental Immunology;2011, p1 

    Commencement of antiretroviral treatment (ART) in severely immunosuppressed HIV-infected persons is associated with unmasking of subclinical disease. The subset of patients that are diagnosed with tuberculosis (TB) disease while on ART have been classified as ART-associated TB. Few studies have...

  • Malignancies, Particularly B-Cell Lymphomas, Are a Frequent Cause of Mortality in Human Immunodeficiency Virus-1 Patients Despite Highly Active Antiretroviral Therapy. Griffin, Daniel O.; Metzger, Michael; Poeth, Kaitlin; Deng, Kathy; Dharsee, Arif; Rico, Juan Carlos; McGowan, Joseph // Open Forum Infectious Diseases;Fall2015, Vol. 2 Issue 4, p1 

    Human immunodeficiency virus (HIV)-1-infected individuals are affected by diseases at rates above those of their HIVnegative peers despite the increased life expectancy of the highly active antiretroviral therapy era. We followed a cohort of approximately 2000 HIV-1-infected patients for 5...

  • When should antiretroviral therapy for HIV be started?  // Nursing Standard;1/31/2007, Vol. 21 Issue 21, p16 

    The article examines the right time to provide antiretroviral therapy for human immunodeficiency virus (HIV) patients in Great Britain. Treatment guidelines have cited from observational cohorts and have concluded that treatment should be first be considered as the CD4 count falls below 350x106/1.

  • Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy. Leung, Victor; Gillis, Jennifer; Raboud, Janet; Cooper, Curtis; Hogg, Robert S.; Loutfy, Mona R.; Machouf, Nima; Montaner, Julio S. G.; Rourke, Sean B.; Tsoukas, Chris; Klein, Marina B. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: HIV leads to CD4:CD8 ratio inversion as immune dysregulation progresses. We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI)...

  • Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. May, Margaret T; Hogg, Robert S; Justice, Amy C; Shepherd, Bryan E; Costagliola, Dominique; Ledergerber, Bruno; Thiébaut, Rodolphe; Gill, M John; Kirk, Ole; van Sighem, Ard; Saag, Michael S; Navarro, Gemma; Sobrino-Vegas, Paz; Lampe, Fiona; Ingle, Suzanne; Guest, Jodie L; Crane, Heidi M; D’Arminio Monforte, Antonella; Vehreschild, Jörg J; Sterne, Jonathan AC // International Journal of Epidemiology;Dec2012, Vol. 41 Issue 6, p1807 

    Background HIV cohort collaborations, which pool data from diverse patient cohorts, have provided key insights into outcomes of antiretroviral therapy (ART). However, the extent of, and reasons for, between-cohort heterogeneity in rates of AIDS and mortality are unclear.Methods We obtained data...

  • Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival. Walensky, Rochelle P.; Wood, Robin; Weinstein, Milton C.; Martinson, Neil A.; Losina, Elena; Fofana, Mariam O.; Goldie, Sue J.; Divi, Nomita; Yazdanpanah, Yazdan; Bingxia Wang; Paltiel, A. David; Freedberg, Kenneth A. // Journal of Infectious Diseases;5/1/2008, Vol. 197 Issue 9, p1324 

    Background. Only 33% of eligible human immunodeficiency virus (HIV)-infected patients in South Africa receive antiretroviral therapy (ART). We sought to estimate the impact of alternative ART scale-up scenarios on patient outcomes from 2007-2012. Methods. Using a simulation model of HIV...

  • Cancer Burden Shifts for People With HIV/AIDS.  // JNCI: Journal of the National Cancer Institute;May2011, Vol. 103 Issue 9, pNP 

    The article discusses the findings of research about the incidence and types of cancer among people with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) in the U.S. According to researchers from the National Cancer Institute (NCI) and the Centers for Disease Control...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics